These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8797514)

  • 1. Borderline ovarian tumors in Finland: epidemiology and familial occurrence.
    Auranen A; Grénman S; Mäkinen J; Pukkala E; Sankila R; Salmi T
    Am J Epidemiol; 1996 Sep; 144(6):548-53. PubMed ID: 8797514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study.
    Madsen C; Baandrup L; Dehlendorff C; Kjaer SK
    Acta Obstet Gynecol Scand; 2015 Jan; 94(1):86-94. PubMed ID: 25256594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-based cohort investigations of the risk for malignant tumors in first-degree relatives and wives of men with breast cancer.
    Olsson H; Andersson H; Johansson O; Möller TR; Kristoffersson U; Wenngren E
    Cancer; 1993 Feb; 71(4):1273-8. PubMed ID: 8435804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Borderline ovarian tumors in Sweden 1960-2005: trends in incidence and age at diagnosis compared to ovarian cancer.
    Skírnisdóttir I; Garmo H; Wilander E; Holmberg L
    Int J Cancer; 2008 Oct; 123(8):1897-901. PubMed ID: 18661518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A decreasing incidence of ovarian carcinoma in Israel.
    Menczer J; Liphshitz I; Barchana M
    Int J Gynecol Cancer; 2006; 16(1):41-4. PubMed ID: 16445608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term survival in women with borderline ovarian tumors: a population-based survey of borderline ovarian tumors in Sweden 1960-2007.
    Kalapotharakos G; Högberg T; Bergfeldt K; Borgfeldt C
    Acta Obstet Gynecol Scand; 2016 Apr; 95(4):473-9. PubMed ID: 26714557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in incidence of borderline ovarian tumors in Denmark 1978-2006.
    Hannibal CG; Huusom LD; Kjaerbye-Thygesen A; Tabor A; Kjaer SK
    Acta Obstet Gynecol Scand; 2011 Apr; 90(4):305-12. PubMed ID: 21306323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer risk in close relatives of women with early-onset breast cancer--a population-based incidence study.
    Olsen JH; Seersholm N; Boice JD; Krüger Kjaer S; Fraumeni JF
    Br J Cancer; 1999 Feb; 79(3-4):673-9. PubMed ID: 10027348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Borderline ovarian tumors in Denmark 1997-2018: Time trends in incidence by histology, age and educational level.
    Baandrup L; Faber MT; Aalborg GL; Kjaer SK
    Acta Obstet Gynecol Scand; 2021 Mar; 100(3):436-443. PubMed ID: 33010027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial invasive and borderline ovarian tumors by proband status, age and histology.
    Hemminki K; Granström C
    Int J Cancer; 2003 Jul; 105(5):701-5. PubMed ID: 12740921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence of borderline ovarian tumors in Israel: a population-based study.
    Iscovich J; Shushan A; Schenker JG; Paltiel O
    Cancer; 1998 Jan; 82(1):147-51. PubMed ID: 9428491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for epithelial ovarian tumours of borderline malignancy.
    Parazzini F; Restelli C; La Vecchia C; Negri E; Chiari S; Maggi R; Mangioni C
    Int J Epidemiol; 1991 Dec; 20(4):871-7. PubMed ID: 1800425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second neoplasms after invasive and borderline ovarian cancer.
    Levi F; Randimbison L; Blanc-Moya R; La Vecchia C
    Eur J Cancer Prev; 2009 Jun; 18(3):216-9. PubMed ID: 19491608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased risk of second cancer among patients with ovarian borderline tumors.
    Bouchardy C; Fernandez S; Merglen A; Usel M; Fioretta G; Rapiti E; Schubert H; Pelte MF; Chappuis PO; Vlastos G
    Gynecol Oncol; 2008 May; 109(2):210-4. PubMed ID: 18377966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in the incidence of ovarian cancer and borderline tumours in Norway, 1954-1993.
    Bjørge T; Engeland A; Hansen S; Tropé CG
    Int J Cancer; 1997 May; 71(5):780-6. PubMed ID: 9180146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demographic and genetic characteristics of patients with borderline ovarian tumors as compared to early stage invasive ovarian cancer.
    Gotlieb WH; Chetrit A; Menczer J; Hirsh-Yechezkel G; Lubin F; Friedman E; Modan B; Ben-Baruch G;
    Gynecol Oncol; 2005 Jun; 97(3):780-3. PubMed ID: 15893369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer incidence in the first-degree relatives of ovarian cancer patients.
    Auranen A; Pukkala E; Mäkinen J; Sankila R; Grénman S; Salmi T
    Br J Cancer; 1996 Jul; 74(2):280-4. PubMed ID: 8688336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic alterations of serous borderline tumors of the ovary compared to stage I serous ovarian carcinomas.
    Osterberg L; Akeson M; Levan K; Partheen K; Zetterqvist BM; Brännström M; Horvath G
    Cancer Genet Cytogenet; 2006 Jun; 167(2):103-8. PubMed ID: 16737908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Borderline and invasive epithelial ovarian tumors in young women.
    Carter J; Fowler J; Carlson J; Carson L; Twiggs LB
    Obstet Gynecol; 1993 Nov; 82(5):752-6. PubMed ID: 8414321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.